Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin.
Affiliation
Cancer Research Campaign Department of Medical Oncology, University of Manchester, Christie Hospital and Holt Radium Institute, Wilmslow Road, Manchester M20 9BX, United Kingdom.Issue Date
1981-04
Metadata
Show full item recordCitation
Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin. 1981, 17 (4):465-9 Eur J CancerJournal
European journal of cancerDOI
10.1016/0014-2964(81)90256-5PubMed ID
7308256Type
ArticleLanguage
enISSN
0014-2964ae974a485f413a2113503eed53cd6c53
10.1016/0014-2964(81)90256-5
Scopus Count
Collections
Related articles
- Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
- Authors: Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM
- Issue date: 1976 Feb
- [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
- Authors: Pullmann H, Muth M
- Issue date: 1982 Feb 15
- Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapy.
- Authors: Castel T, Estapé J, Viñolas N, Mascaró JM, Castro J, Vilalta A, Gratacós R, Daniels M, Palou J, Grau JJ
- Issue date: 1991
- Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
- Authors: Wood WC, Cosimi AB, Carey RW, Kaufman SD
- Issue date: 1978 Jun
- A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
- Authors: Sterchi JM, Wells HB, Case LD, Spurr CL, White DR, Richards F, Muss HB, Jackson DV, Stuart JJ, Cooper MR
- Issue date: 1985 Feb 15